Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention
Table 1
Comparison of the clinical characteristics between group A (experimental group) and group B (control group).
Items
Group A (n = 32)
Group B (n = 30)
Age (years)
66.59 ± 9.86
66.14 ± 10.03
0.877
Male (case)
20
17
0.640
Smoking (case)
22
22
0.691
Drinking (case)
18
16
0.818
Hypertension (case)
25
17
0.071
T2DM (case)
14
9
0.263
Hyperlipemia (case)
18
17
0.974
OMI (case)
7
9
0.465
HF (case)
6
6
0.901
ACEI/ARB (case)
30
29
0.593
Statins (case)
32
30
-
β-Blocker (case)
28
29
0.355
Aspirin (case)
32
30
—
Clopidogrel (case)
32
30
—
HbA1c (%)
6.67 ± 1.44
6.61 ± 1.14
0.581
CHO (mmol/L)
3.89 ± 0.84
4.14 ± 1.13
0.218
LDL-C (mmol/L)
2.32 ± 0.70
2.48 ± 0.90
0.181
ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor blocker; HbA1c: hemoglobin A1c; CHO: cholesterol; and LDL-C: low-density lipoprotein cholesterol.
